NXCLF yields 1.97% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, NXCLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXCLF + PFE for your $10,000?
LIFULL Co., Ltd. provides real estate information services in Japan. It offers LIFULL HOME'S, a site of real estate and housing information; LIFULL Revitalize Rural Japan that suggest new lifestyles to people in Japan based on refurbishment of abandoned houses; LIFULL Move that provides reviews and rankings of the moving companies; LIFULL Nursing Care, a special care facility searching web service; LIFULL Life Plan that provide the opportunity for updating life plan; LIFULL FLOWER, an online flower gift shop; and LIFULL Investment, a money funding website. The company also provides LIFULL FaM that enables working mothers balance childcare with work while pursuing a career; LIFULL rental spaces, a site for rental spaces and meeting rooms, event venues, and other rental facilities; LIFULL Storage, a storage space searching web service; LIFULL HUB, a shared office; LIFULL Fab to expand possibilities of design and craftsmanship; LIFULL Table, a mixed-style deli restaurant; and LIFULL Marketing Partners that offers full Web assistance for real estate related companies. In addition, it offers LivingAnywhere Commons, a community to live; instant house products; LIFULL Real Estate Crowdsourcing, an online advertising platform for property crowd funding projects; Trovit, an aggregation website; and Mitula, a site that provides information in real estate and housing, used cars, recruitment, and fashion. The company was formerly known as NEXT Co., Ltd. and changed its name to LIFULL Co., Ltd.in April 2017. LIFULL Co., Ltd. was founded in 1997 and is headquartered in Tokyo, Japan.
Full NXCLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.